首页> 外文期刊>Artificial Organs >Beating-Heart Coronary Artery Bypass Grafting With Miniaturized Cardiopulmonary Bypass Results in a More Complete Revascularization When Compared to Off-Pump Grafting
【24h】

Beating-Heart Coronary Artery Bypass Grafting With Miniaturized Cardiopulmonary Bypass Results in a More Complete Revascularization When Compared to Off-Pump Grafting

机译:与非体外循环皮瓣移植相比,心脏搏动性冠状动脉旁路移植术与微型心肺旁路移植术的血运重建更完全

获取原文
获取原文并翻译 | 示例

摘要

The technique of miniaturized cardiopulmonary bypass (M-CPB) for beating-heart coronary artery bypass grafting (CABG) is relatively new and has potential advantages when compared to conventional cardiopulmonary bypass (CPB). M-CPB consists of less tubing length and requires less priming volume. The system is phosphorylcholine coated and results in minimal pump-related inflammatory response and organ injury. Finally, this technique combines the advantages of the off-pump CABG (OPCAB) with the better exposure provided by CPB to facilitate complete revascularization. The hypothesis is that CABG with M-CPB has a better outcome in terms of complete coronary revascularization and perioperative results as that compared to off-pump CABG (OPCAB). In a retrospective study, 302 patients underwent beating-heart CABG, 117 (39%) of them with the use of M-CPB and 185 (61%) with OPCAB. After propensity score matching 62 patients in both groups were demographically similar. The most important intra- and early-postoperative parameters were analyzed. Endpoints were hospital mortality and complete revascularization. Hospital mortality was comparable between the groups. The revascularization was significantly more complete in M-CPB patients than in patients in the OPCAB group. Beating-heart CABG with M-CPB is a safe procedure and it provides an optimal operative exposure with significantly more complete coronary revascularization when compared to OPCAB. Beating-heart CABG with the support of a M-CPB is the operation of choice when total coronary revascularization is needed.
机译:与常规心肺旁路(CPB)相比,用于搏动心脏冠状动脉旁路移植术(CABG)的微型心肺旁路术(M-CPB)相对较新,具有潜在优势。 M-CPB由较短的管路长度组成,需要的灌注体积也较小。该系统涂有磷酸胆碱,可将泵相关的炎症反应和器官损伤降至最低。最后,该技术结合了非体外循环CABG(OPCAB)的优势和CPB提供的更好的暴露,以促进完全的血运重建。假设是,与非体外循环CABG(OPCAB)相比,具有M-CPB的CABG在完全冠脉血运重建和围手术期效果方面具有更好的结局。在一项回顾性研究中,有302例患者接受了心脏跳动CABG治疗,其中117例(39%)接受了M-CPB的治疗,185例(61%)接受了OPCAB的治疗。倾向得分匹配后,两组中的62例患者在人口统计学上相似。分析了术后最重要的术中和术后参数。终点是医院死亡率和完全血运重建。两组之间的医院死亡率相当。与OPCAB组的患者相比,M-CPB患者的血运重建更加彻底。与OPCAB相比,带有M-CPB的心脏搏动性CABG是一种安全的程序,它可提供最佳的手术暴露,并显着更彻底地进行冠状动脉血运重建。当需要进行总的冠脉血运重建时,在M-CPB的支持下进行心脏搏动CABG是首选手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号